10% QoQ improvement in US sales (led by gRenvela) was a positive, however adj. EBITDA margin at 18.2% (down 475 bps YoY/ 50 bps QoQ) was below our expectation. Management expects pricing pressure in US to continue given channel consolidation and increased competition.